다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

ORGS

Orgenesis (ORGS)

Orgenesis Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ORGS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/16	05:01	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:ORGS	Orgenesis Inc
2024/05/07	04:30	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ORGS	Orgenesis Inc
2024/05/07	04:28	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ORGS	Orgenesis Inc
2024/05/07	04:26	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ORGS	Orgenesis Inc
2024/04/16	06:07	GlobeNewswire Inc.	Orgenesis Provides Year End Business Update	NASDAQ:ORGS	Orgenesis Inc
2024/04/11	01:00	GlobeNewswire Inc.	Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility	NASDAQ:ORGS	Orgenesis Inc
2024/03/18	21:30	GlobeNewswire Inc.	Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference	NASDAQ:ORGS	Orgenesis Inc
2024/03/13	21:30	GlobeNewswire Inc.	Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes	NASDAQ:ORGS	Orgenesis Inc
2024/03/04	22:30	GlobeNewswire Inc.	Orgenesis Inc. Announces $2.3 Million Private Placement	NASDAQ:ORGS	Orgenesis Inc
2024/02/29	22:30	GlobeNewswire Inc.	Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing	NASDAQ:ORGS	Orgenesis Inc
2024/01/31	23:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORGS	Orgenesis Inc
2024/01/31	23:15	GlobeNewswire Inc.	Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic	NASDAQ:ORGS	Orgenesis Inc
2024/01/25	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORGS	Orgenesis Inc
2024/01/23	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORGS	Orgenesis Inc
2024/01/09	07:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ORGS	Orgenesis Inc
2024/01/09	07:36	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ORGS	Orgenesis Inc
2024/01/05	20:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORGS	Orgenesis Inc
2023/11/14	22:30	GlobeNewswire Inc.	Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TM	NASDAQ:ORGS	Orgenesis Inc
2023/11/14	06:15	GlobeNewswire Inc.	Orgenesis Provides Business Update for the Third Quarter of 2023	NASDAQ:ORGS	Orgenesis Inc
2023/11/14	06:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ORGS	Orgenesis Inc
2023/11/09	21:41	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ORGS	Orgenesis Inc
2023/11/08	23:24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORGS	Orgenesis Inc
2023/11/08	23:00	GlobeNewswire Inc.	Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offering	NASDAQ:ORGS	Orgenesis Inc
2023/11/02	21:00	GlobeNewswire Inc.	Orgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant Funding	NASDAQ:ORGS	Orgenesis Inc
2023/10/31	10:30	GlobeNewswire Inc.	Orgenesis Announces Withdrawal of Proposed Public Offering	NASDAQ:ORGS	Orgenesis Inc
2023/10/31	05:07	GlobeNewswire Inc.	Orgenesis Announces Proposed Underwritten Public Offering	NASDAQ:ORGS	Orgenesis Inc
2023/09/21	21:00	GlobeNewswire Inc.	CGT Global and Octomera Enter Agreement to Expand Cell & Gene Therapy Development and Patient Access Across the United States	NASDAQ:ORGS	Orgenesis Inc
2023/09/09	05:05	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:ORGS	Orgenesis Inc
2023/09/06	20:00	GlobeNewswire Inc.	Cell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard Bauer, Joins Orgenesis Business, Octomera, to Drive Continued Expansion of POCare Facilities and Service Support	NASDAQ:ORGS	Orgenesis Inc
2023/09/06	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ORGS	Orgenesis Inc

검색 관련기사 보기:NASDAQ:ORGS

1 2 3 4 5 6 7 8 9 10 다음 >>

MMA Capital Management LLC

Zombie Inu [OLD]

Kairos Minerals

Telesystem Wireless

Klondike Silver (PK)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관